Stanford (1)

Adrenal Gland Tumors (1)

Carcinoid Tumors (1)

Multiple Endocrine Neoplasia (1)

Neuroblastoma (1)

Neuroendocrine Tumors (1)

Pancreatic Neuroendocrine Tumors (1)

Terminated (1)

phase 2 (1)

Pamela L. Kunz (1)

Genentech, Inc. (1)

erlotinib (1)

pertuzumab (1)

drug (1)

Other (1)

Interventional (1)

adrenal gland tumors

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Terminated

Jan 12, 2017